Dr Reddys Laboratories (RDY) Non-Current Receivables (2017 - 2025)
Historic Non-Current Receivables for Dr Reddys Laboratories (RDY) over the last 9 years, with Q3 2025 value amounting to $42.6 million.
- Dr Reddys Laboratories' Non-Current Receivables rose 5647.57% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year increase of 5647.57%. This contributed to the annual value of $21.0 million for FY2025, which is 5333.33% down from last year.
- According to the latest figures from Q3 2025, Dr Reddys Laboratories' Non-Current Receivables is $42.6 million, which was up 5647.57% from $21.0 million recorded in Q1 2025.
- Dr Reddys Laboratories' 5-year Non-Current Receivables high stood at $44.8 million for Q1 2024, and its period low was $718150.0 during Q1 2022.
- In the last 5 years, Dr Reddys Laboratories' Non-Current Receivables had a median value of $29.9 million in 2023 and averaged $25.5 million.
- Per our database at Business Quant, Dr Reddys Laboratories' Non-Current Receivables tumbled by 9325.04% in 2021 and then soared by 445155.0% in 2023.
- Dr Reddys Laboratories' Non-Current Receivables (Quarter) stood at $42.8 million in 2021, then dropped by 10.26% to $38.4 million in 2022, then plummeted by 90.62% to $3.6 million in 2023, then surged by 654.47% to $27.2 million in 2024, then soared by 56.48% to $42.6 million in 2025.
- Its last three reported values are $42.6 million in Q3 2025, $21.0 million for Q1 2025, and $27.2 million during Q3 2024.